Diabetes mellitus, type 2 Trials in Bondy, France
Conditions / Diabetes mellitus, type 2 / Bondy, France
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01106690 | The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone) | COMPLETED | PHASE3 |
| NCT00379769 | RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes | COMPLETED | PHASE3 |
| NCT00749190 | BI 10773 add-on to Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT01289990 | Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00881530 | Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension | COMPLETED | PHASE2 |
| NCT01159600 | Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00283751 | Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01137812 | The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) | COMPLETED | PHASE3 |
| NCT01011868 | Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT00069836 | Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. | COMPLETED | PHASE3 |